Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease – a study within the Europe Against Cancer Program-Reference-Cited by-同舟云学术

Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease – a study within the Europe Against Cancer Program

Published:2004-02-12 Issue:4 Volume:18 Page:884-886
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

van der Velden V H J, ,Boeckx N,Gonzalez M,Malec M,Barbany G,Lion T,Gottardi E,Pallisgaard N,Beillard E,Hop W C J,Hoogeveen P G,Gabert J,van Dongen J J M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2403309.pdf

Reference7 articles.

1. Szczepanski T, Orfao A, van der Velden VH, San Miguel JF, van Dongen JJ . Minimal residual disease in leukaemia patients. Lancet Oncol 2001; 2: 409–417.

2. van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ . Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003; 17: 1013–1034.

3. Gabert J, Beillard E, van der Velden VHJ, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) of fusion gene transcripts for minimal residual disease detection in leukemia – a Europe Against Cancer Program. Leukemia 2003; 17: 2318–2357.

4. Beillard E, Pallisgaard N, van der Velden VHJ, Bi W, Dee R, van der Schoot CE et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe Against Cancer Program. Leukemia 2003; 17: 2474–2486.

5. Tanner MA, Berk LS, Felten DL, Blidy AD, Bit SL, Ruff DW . Substantial changes in gene expression level due to the storage temperature and storage duration of human whole blood. Clin Lab Haematol 2002; 24: 337–341.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute promyelocytic leukemia derived extracellular vesicles conserve PML-RARα transcript from storage-inflicted degradation: a stable diagnosis tool in APL patients;Annals of Hematology;2021-07-08

2. Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1;Leukemia;2019-03-11

3. BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia;Haematologica;2018-07-05

4. Development and evaluation of armored RNA ‐based standards for quantification of BCR ‐ ABL 1 p210/p190 fusion gene transcripts;Journal of Clinical Laboratory Analysis;2018-06-29

5. Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?;Molecular Diagnosis & Therapy;2017-04-27